Pfizer’s Global Medical Grants: Long-acting Growth Hormone Research program

Projects that will be considered for Pfizer support will focus on long-acting growth hormone (LAGH) research, specifically:

  • Morbidities in growth disorders
  • Novel strategies including Quality of Life and Patient Reported Outcomes to evaluate and treat growth disorders
  • Comparison of clinical effects of daily vs long-acting growth hormone
  • Comparative pathophysiology of daily vs long-acting growth hormone
  • Innovative methods to evaluate levels of adherence of daily and longacting growth hormone treatment
  • Novel strategies to address current unmet medical needs in short stature management which could be addressed with long-acting growth hormone treatment

Funding & duration

US $50,000 – $100,000 (approx. AUD $77,000 – $155,000) per year for 1 or 2 years.

Submission requirements & due date

Further information

Need help?

This entry was posted in Funding by Award Type, Funding by Faculty, Grants (Project Funds), Health & Medical Sciences, International Funding. Bookmark the permalink.

Comments are closed.